Curran Terrie
CIK 0001690298
President and Chief ExecutiveDirector
Filings
20
Latest Jun 16, 2025
Issuers covered
3
Showing
20 of 20
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 63% | +9.0% | +10.0% | +60.3% | -19.5% |
| 90 days | 8 | 38% | +6.7% | -7.0% | +77.7% | -26.5% |
| 180 days | 8 | 38% | -19.2% | -24.0% | +47.8% | -74.5% |
| 365 days | 8 | 63% | -7.3% | +20.7% | +57.6% | -121.7% |
Issuers
Companies where Curran Terrie has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | 14 | Mar 3, 2025 |
| ARQT | Arcutis Biotherapeutics, Inc. | 5 | Jun 16, 2025 |
| MYOV | Myovant Sciences Ltd. | 1 | Mar 10, 2023 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|